Summit Financial’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$818K Buy
5,353
+846
+19% +$130K 0.01% 842
2025
Q4
$621K Sell
4,507
-27
-0.6% -$3.54K 0.01% 815
2025
Q3
$581K Sell
4,534
-29
-0.6% -$3.54K 0.01% 843
2025
Q2
$552K Buy
4,563
+243
+6% +$27.4K 0.01% 553
2025
Q1
$482K Sell
4,320
-195
-4% -$20.8K 0.01% 522
2024
Q4
$439K Buy
4,515
+725
+19% +$77.3K 0.02% 470
2024
Q3
$436K Buy
3,790
+339
+10% +$38.5K 0.02% 393
2024
Q2
$367K Sell
3,451
-91
-3% -$9.13K 0.02% 379
2024
Q1
$356K Sell
3,542
-1,487
-30% -$152K 0.02% 302
2023
Q4
$508K Buy
5,029
+388
+8% +$37.5K 0.03% 243
2023
Q3
$473K Buy
4,641
+4
+0.1% +$406 0.03% 242
2023
Q2
$468K Buy
4,637
+981
+27% +$98.1K 0.03% 234
2023
Q1
$336K Sell
3,656
-1,499
-29% -$131K 0.03% 204
2022
Q4
$468K Sell
5,155
-4,334
-46% -$365K 0.04% 177
2022
Q3
$721K Buy
9,489
+871
+10% +$72.2K 0.07% 138
2022
Q2
$728K Sell
8,618
-1,449
-14% -$127K 0.07% 129
2022
Q1
$883K Buy
10,067
+1,327
+15% +$115K 0.07% 127
2021
Q4
$764K Buy
8,740
+2,357
+37% +$196K 0.06% 133
2021
Q3
$522K Buy
6,383
+3,072
+93% +$276K 0.04% 141
2021
Q2
$302K Buy
+3,311
New +$295K 0.03% 129

Other funds holding NVS

Summit Financial's NVS Position: Q1 2026 in Review

Summit Financial increased its Novartis (NVS) stake by 19% in Q1 2026, buying an estimated $130K and bringing the position to 5,353 shares worth $818K. The position accounts for 0.01% of the portfolio, ranked #842.

Summit Financial first reported a position in NVS in Q2 2021 and has held it in 20 quarters since. The position peaked at $883K in Q1 2022. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Summit Financial held 5,353 shares of Novartis worth $818K as of Q1 2026.
  • Summit Financial bought 846 Novartis shares in Q1 2026, an estimated $130K.
  • Novartis made up 0.01% of Summit Financial's portfolio in Q1 2026, its #842 holding.
  • Summit Financial first reported a position in Novartis in Q2 2021 and has held it in 20 quarters since.
  • Summit Financial's Novartis position peaked at $883K in Q1 2022.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.